EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria
Augustinus P. T. van der Ploeg(Erasmus MC Cancer Institute), Alexander M.M. Eggermont(University Medical Center Utrecht), Cornelis Verhoef(Erasmus MC Cancer Institute), Senada Koljenović(University of Antwerp), Alexander C. J. van Akkooi(The University of Sydney), Paul Schmitz(University Hospital Regensburg)
Cited by 61
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k